Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Heart Problems and Downgrades Cause Dow Stocks to Fall

After a seven-day winning streak for the Dow Jones Industrial Average (DJINDICES: ^DJI  ) , today may be the day when investors begin to take profits. As of 12:55 p.m. EDT, the blue-chip index is up less than a point, having traded within a tight range all day. There are more losers than winners on the Dow, but a big gain by Merck (NYSE: MRK  ) is helping to keep the index afloat.

It's important for long-term individual investors to remember that day-traders, money managers, and other Wall Street types will begin taking profits now that the markets have run so high so quickly. If the Dow falls in the short term, don't panic or follow the herd off the cliff.

The S&P 500 is down 0.23%, while the NASDAQ has lost 0.4%.

Today's Dow laggards
The Dow's big pharmaceutical stocks are heading in opposite directions today. Shares of Merck rose by 3.3% after an independent monitoring board gave the company's cholesterol drug Vytorin a pass, allowing its drug trial to continue. This drug could be a blockbuster for Merck, similar to Pfizer's (NYSE: PFE  ) Lipitor.

Speaking of which, Pfizer is seeing much less success today, with shares down 0.8%. Shares began falling this morning after the U.S. Food and Drug Administration released a warning that Pfizer's antibiotic Zithromax can cause a life-threating irregular heartbeat. A research study performed by The New England Journal of Medicine back in May concluded that Pfizer's drug carried a higher risk of cardiovascular death than various other antibacterial drugs.

Shares of Cisco (NASDAQ: CSCO  ) are lower by 1.3% today after Standpoint Research downgraded the stock this morning from a buy to a hold. Cisco did recently hit a new 52-week high at $21.98, which may have prompted Standpoint's analysts to change their rating.

Another Dow stock moving lower after a recent downgrade is General Electric (NYSE: GE  ) . Yesterday, Shannon O'Callaghan from Nomura Securities downgraded the stock from buy to neutral, although he kept his price target at $24 per share. General Electric's stock is currently down 1%.

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in the brand-new free report: "The Motley Fool's Top Stock for 2013." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (0) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2307912, ~/Articles/ArticleHandler.aspx, 9/25/2016 8:27:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes